Cisbio Bioassays, developer of products, technologies and services used for assay development and drug screening and for in vitro diagnostics, has announced that it has signed a global distribution agreement with BellBrook Labs, provider of high throughput screening tools, for BellBrook Labs’ Transcreener EPIGEN Methyltransferase assay.
Under the terms of the agreement, Cisbio Bioassays will offer this universal, fluorescence polarization-based tool for drug discovery studies in the growing field of epigenetics to pharmaceutical and biotechnology researchers in Europe, the United States and Asia through its network of sales teams.
